Aini Nur, Putri Alfiani Rahmi, Banda Kondwani Joseph, Janitra Fitria Endah
School of Nursing, College of Nursing, Taipei Medical University, Taipei, Taiwan.
Basic Nursing Department, Faculty of Health Sciences, University of Muhammadiyah Malang, Malang, Indonesia.
Sleep Biol Rhythms. 2024 Dec 20;23(2):101-112. doi: 10.1007/s41105-024-00561-w. eCollection 2025 Apr.
Sleep disorders are the most distressing non-motor problems among Parkinson's disease (PD), whereas obstructive sleep apnea (OSA) is a type of sleep disorder that commonly occurs in Parkinson's disease. Therefore, we conducted this meta-analysis to estimate the prevalence of OSA in Parkinson's disease. A comprehensive search in CINAHL, Embase, Ovid MEDLINE, PubMed, Scopus, and Web of Science, following the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines, was conducted from inception to September 2023 to identify studies on the prevalence of PD patients with OSA. A Comprehensive Meta-Analysis software version 3.0 and R software with random-effects models were used for pooled prevalence and prediction interval analysis. We assessed heterogeneity using test and Cochran's Q-statistic and study quality with Hoy's risk of bias. Moreover, meta-regression and subgroup analysis identified factors contributing to prevalence. A total of 42 studies with 3342 participants were included. The pooled prevalence of OSA among Parkinson's disease patients was 45% (95% CI: 39-52%). Based on 95% prediction interval, the future prevalence of OSA in PD was expected to vary from 13 to 83%. Moderator analyses showed that male sex, higher BMI, and country geographical area were significantly associated with OSA prevalence, in which South and North America are the top two continents that have a high prevalence of OSA. This study gives a comprehensive overview of the high prevalence of OSA and associated factors in Parkinson's disease, which can be used for planning care and future research.
The online version contains supplementary material available at 10.1007/s41105-024-00561-w.
睡眠障碍是帕金森病(PD)中最令人苦恼的非运动问题,而阻塞性睡眠呼吸暂停(OSA)是一种常见于帕金森病的睡眠障碍类型。因此,我们进行了这项荟萃分析,以估计帕金森病中阻塞性睡眠呼吸暂停的患病率。按照系统评价和荟萃分析的首选报告项目(PRISMA)指南,从创刊至2023年9月,在CINAHL、Embase、Ovid MEDLINE、PubMed、Scopus和Web of Science中进行了全面检索,以确定关于帕金森病合并阻塞性睡眠呼吸暂停患者患病率的研究。使用综合荟萃分析软件版本3.0和具有随机效应模型的R软件进行合并患病率和预测区间分析。我们使用I²检验和Cochran's Q统计量评估异质性,并使用Hoy的偏倚风险评估研究质量。此外,荟萃回归和亚组分析确定了影响患病率的因素。共纳入42项研究,3342名参与者。帕金森病患者中阻塞性睡眠呼吸暂停的合并患病率为45%(95%CI:39 - 52%)。基于95%预测区间,预计帕金森病中阻塞性睡眠呼吸暂停的未来患病率在13%至83%之间变化。调节因素分析表明,男性、较高的体重指数和国家地理区域与阻塞性睡眠呼吸暂停患病率显著相关,其中南美洲和北美洲是阻塞性睡眠呼吸暂停患病率最高的两大洲。本研究全面概述了帕金森病中阻塞性睡眠呼吸暂停的高患病率及相关因素,可用于规划护理和未来研究。
在线版本包含可在10.1007/s41105-024-00561-w获取的补充材料。